Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Having a diagnosis of resectable non-small cell lung cancer (NSCLC)
Being 18 years or above at the time of their NSCLC diagnosis
Having initiated a neoadjuvant treatment with nivolumab and chemotherapy outside a clinical trial
Being indexed in the site database
Being followed at the site for at least 5 months, except for patients with a record of death
You may not be if
Having any primary tumor other than NSCLC on or before the date of NSCLC diagnosis that required a treatment ending less than 12-months before the nivolumab plus chemotherapy neoadjuvant treatment
